1. What Is the Peripherally Inserted Central Catheter (PICC) Line Market?
The Peripherally Inserted Central Catheter (PICC) Line Market comprises catheter systems inserted through peripheral upper extremity veins and advanced to the superior vena cava-right atrium junction to provide central venous access. This route avoids internal jugular, subclavian, and femoral vein puncture. The market includes single and double-lumen PICC lines in standard and valved-tip configurations, power-injectable PICCs cleared for contrast injection, and PICC insertion accessories including ultrasound-guided introducer kits and tip verification systems. These catheters are inserted at the bedside by trained IV nurses, PICC nurse specialists, and interventional radiologists using ultrasound guidance. They provide medium-duration central venous access for antibiotic therapy, chemotherapy, parenteral nutrition, and repeated blood sampling. Market scope covers PICC line catheters and their insertion accessory kits, and excludes conventional central venous catheters, midline catheters, and PICC tip position verification imaging systems.
2. Peripherally Inserted Central Catheter (PICC) Line Market Size & Forecast
3. Emerging Technologies
- PICC catheter antimicrobial surface functionalisation is advancing through silver nanoparticle incorporation into polyurethane polymer matrices that provide sustained antimicrobial activity throughout catheter dwell without leaching systemic antimicrobial concentrations. Growing hospital infection control interest in.
- Wireless intravascular electrocardiogram PICC tip guidance is advancing integration of ECG electrode arrays into catheter stylets that display real-time intracardiac P-wave morphology during PICC advancement to identify the SVC-RA junction without imaging. Increasing adoption.
- Biodegradable PICC securing devices are advancing as adhesive-free catheter stabilisation systems using biocompatible degradable polymer anchors that dissolve after catheter removal without leaving adhesive residue on patient skin. Growing hospital preference for securement methods.
- AI-powered PICC insertion guidance platforms are advancing image analysis algorithms that identify optimal basilic and cephalic vein insertion sites from real-time ultrasound feeds and predict successful cannulation probability based on vessel diameter. Growing industry adoption of this technology is motivating development.
Similar technologies are also transforming adjacent markets. Learn more in our Haemodialysis Catheter Market.
4. Key Market Opportunity
A key opportunity in the Peripherally Inserted Central Catheter (PICC) Line Market is the expansion of PICC-enabled outpatient parenteral antibiotic therapy programmes for patients who currently receive prolonged IV antibiotic courses as inpatients due to inadequate OPAT infrastructure. A significant proportion of patients requiring 2 to 6 weeks of intravenous antibiotic therapy for endocarditis, osteomyelitis, and septic arthritis remain hospitalised for the full course at facilities without established OPAT programmes, generating avoidable bed utilisation and hospital costs. Growing OPAT programme development at community hospitals and infectious disease outpatient clinics, combined with expanding PICC nurse insertion capacity, is creating the clinical infrastructure needed to safely discharge stable IV antibiotic patients with PICC-based home therapy. PICC manufacturers that provide OPAT programme development toolkits, nursing training resources, and catheter supply agreements designed for home healthcare providers are positioned to capture growing PICC volume from the expanding outpatient antibiotic therapy market.
5. Top Companies in the Peripherally Inserted Central Catheter (PICC) Line Market
The following organisations hold leading positions in the Peripherally Inserted Central Catheter (PICC) Line Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Becton Dickinson
- Teleflex
- B. Braun Melsungen
- AngioDynamics
- Smiths Medical
- ICU Medical
- Argon Medical Devices
- Access Scientific
- Vascular Pathways
- Merit Medical
6. Market Segmentation
The Peripherally Inserted Central Catheter (PICC) Line Market is analysed across 6 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Lumen Configuration | Single-Lumen PICC Double-Lumen PICC Triple-Lumen PICC |
| By Catheter Material | Polyurethane Standard Polyurethane Antimicrobial-Impregnated Polyurethane Silicone Standard Silicone Silicone with Antimicrobial Coating |
| By Power Injectability | Power-Injectable PICC Standard Non-Power PICC |
| By Application | Antibiotic Therapy OPAT Outpatient Parenteral Antibiotic Short-Course Inpatient IV Antibiotic Chemotherapy Vesicant Chemotherapy Infusion Non-Vesicant Chemotherapy Total Parenteral Nutrition Home TPN Programme Hospital Inpatient TPN Blood Sampling |
| By End User | Hospitals Acute Care Hospital Inpatient Long-Term Acute Care Hospital Home Healthcare Home Infusion Therapy Agency Skilled Nursing Facility Ambulatory Care Centres Outpatient Infusion Clinic Oncology Infusion Centre |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Peripherally Inserted Central Catheter (PICC) Line Market trajectory over the forecast period:
Power-Injectable PICC Technology Is Enabling CT and MRI Contrast Administration Through Peripherally Inserted Central Access.Radiology departments and oncology teams at hospitals with high CT scanning patient populations are standardising power-injectable PICCs across all central line insertions to eliminate the need for separate peripheral IV cannula placement. For contrast injection during imaging procedures. Becton Dickinson expanded its PowerPICC SOLO power-injectable catheter range with additional lumen configurations optimised for oncology patients requiring combined chemotherapy. This imags contrast delivery in 2024, addressing growing clinical demand for power-injectable capacity across cancer care pathways.
Ultrasound-Guided PICC Insertion Programmes Are Expanding to Enable Bedside Nurse-Led Insertion Without Physician Involvement.Hospital IV therapy teams and vascular access nurse specialists are adopting structured ultrasound-guided PICC insertion training programmes that enable certified bedside nurses to perform PICC insertions independently, reducing patient waiting times. Procedure delays associated with physician-dependent insertion models. Teleflex expanded its Arrow PICC insertion training and certification programme with updated ultrasound-guided technique curriculum for IV therapy nurses in 2024. This enables hospitals to build internal nursing PICC insertion capacity as a component of vascular access service development.
Magnetic Tip Confirmation Technology Is Replacing Chest X-Ray for PICC Tip Position Verification at the Bedside.PICC nurse specialists and IV therapy teams are adopting electromagnetic tip confirmation systems that use magnetic stylet tracking to verify PICC tip position at the CAJ without chest X-ray. This enables same-session PICC use initiation and reducing radiology department workflow burden. Becton Dickinson continued commercial expansion of the Sherlock 3CG Tip Confirmation System in additional hospital markets in 2024, providing PICC insertion teams. FDA-cleared bedside tip position verification for chest X-ray elimination in appropriate patient populations.
For related market intelligence, see the Central Venous Catheter Market.
8. Segmental Analysis
By lumen configuration, double-lumen PICCs dominated the Peripherally Inserted Central Catheter (PICC) Line Market in 2025, driven by clinical preference for dual-access configurations enabling simultaneous drug infusion and blood sampling from separate lumens. Clinical nurses and IV therapy teams continue specifying double-lumen PICCs as the standard configuration for oncology and antibiotic therapy patients where simultaneous multi-drug infusion and blood sampling require separate ports. Power-injectable PICCs are the fastest-growing lumen category, driven by growing hospital-wide adoption as the standard type enabling CT contrast injection through the existing PICC without additional peripheral cannula placement. Radiology-oncology clinical pathways at cancer centres are increasing power-injectable PICC specification across all new cancer patient insertions as integrated contrast capability reduces burden during serial CT staging examinations.
By application, antibiotic therapy dominated the Peripherally Inserted Central Catheter (PICC) Line Market in 2025, driven by the high volume of prolonged IV antibiotic courses requiring reliable central access beyond peripheral cannula dwell tolerance. Infectious disease physicians and hospital discharge planning teams continue specifying PICC insertion for antibiotic therapy patients requiring courses exceeding 7 days where peripheral IV reliability would limit therapy completion. Chemotherapy delivery is the fastest-growing application, driven by growing ambulatory oncology populations requiring central venous access for vesicant chemotherapy incompatible with peripheral administration. Oncology infusion nurses and medical oncologists are increasing PICC insertion rates as ambulatory cancer volumes grow and guidelines advise against prolonged vesicant infusion through peripheral catheters.
9. Regional Analysis
Regional demand patterns across the Peripherally Inserted Central Catheter (PICC) Line Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Peripherally Inserted Central Catheter (PICC) Line Market in 2025, holding 38.0% of the global market. The region's dominance reflects the high volume of outpatient antibiotic therapy, oncology infusion, and home parenteral nutrition programmes that rely on PICC lines, a large certified PICC nurse specialist workforce, and established reimbursement for PICC insertion in hospital and home settings. The well-developed home healthcare and outpatient infusion therapy infrastructure in the United States creates consistent PICC demand as hospital discharge planning teams routinely place PICCs for patients transitioning from inpatient IV therapy to home-based administration. Growing adoption of bedside PICC insertion programmes with electromagnetic tip confirmation at United States hospitals is reducing interventional radiology dependence and improving PICC service throughput, enabling higher insertion volumes without procedural scheduling delays.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 9.80% during the forecast period. Growing hospital capacity, increasing IV therapy programme sophistication, and expanding outpatient antibiotic and chemotherapy service development in China, India, Japan, and South Korea are creating growing demand for PICC lines as a preferred vascular access solution for medium-duration therapy. Healthcare authority investment in reducing hospital length of stay and developing outpatient infusion infrastructure across the region is creating clinical adoption pathways for PICC-enabled early discharge programmes that mirror established Western OPAT and home infusion models. Local PICC catheter manufacturing development in China is producing domestically available PICC products at competitive price points, improving access to quality central venous access technology at public hospital IV therapy programmes managing growing patient volumes.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Peripherally Inserted Central Catheter (PICC) Line Market was valued at USD 1.29 Bn in 2025 and is projected to reach USD 2.38 Bn by 2034, growing at a CAGR of 7.00% over the 2026–2034 forecast period.
The Peripherally Inserted Central Catheter (PICC) Line Market is projected to grow at a CAGR of 7.00% from 2026 to 2034.
North America accounted for the largest share of the Peripherally Inserted Central Catheter (PICC) Line Market in 2025, holding 38.0% of the global market.
The leading companies in the Peripherally Inserted Central Catheter (PICC) Line Market include Becton Dickinson, Teleflex, B. Braun Melsungen, AngioDynamics, Smiths Medical, ICU Medical, Argon Medical Devices, Access Scientific, Vascular Pathways, Merit Medical.
Power-injectable picc technology is enabling ct and mri contrast administration through peripherally inserted central access.
By lumen configuration, double-lumen PICCs dominated the Peripherally Inserted Central Catheter (PICC) Line Market in 2025, driven by clinical preference for dual-access configurations enabling simultaneous drug infusion and blood sampling from separate lumens.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.